1.中国中医科学院望京医院,北京市朝阳区望京中环南路6号
2.北京中医药大学东直门医院
3.湖北省中医院
xwduan@ sina.com
收稿:2024-10-11,
修回:2025-03-10,
纸质出版:2025-06-02
移动端阅览
李丹阳,尹强,朱泽兵等.疏肝健脾颗粒联合除湿止痒软膏治疗特应性皮炎合并睡眠障碍肝郁脾虚证的随机对照试验[J].中医杂志,2025,66(11):1133-1139.
LI Danyang,YIN Qiang,ZHU Zebing,et al.Shugan Jianpi Granules (疏肝健脾颗粒) Combined with Chushi Zhiyang Oinement (除湿止痒软膏) for Atopic Dermatitis with Sleep Disturbance of Liver Constraint and Spleen Deficiency Syndrome: A Randomized Controlled Trial[J].Journal of Traditional Chinese Medicine,2025,66(11):1133-1139.
李丹阳,尹强,朱泽兵等.疏肝健脾颗粒联合除湿止痒软膏治疗特应性皮炎合并睡眠障碍肝郁脾虚证的随机对照试验[J].中医杂志,2025,66(11):1133-1139. DOI: 10.13288/j.11-2166/r.2025.11.009.
LI Danyang,YIN Qiang,ZHU Zebing,et al.Shugan Jianpi Granules (疏肝健脾颗粒) Combined with Chushi Zhiyang Oinement (除湿止痒软膏) for Atopic Dermatitis with Sleep Disturbance of Liver Constraint and Spleen Deficiency Syndrome: A Randomized Controlled Trial[J].Journal of Traditional Chinese Medicine,2025,66(11):1133-1139. DOI: 10.13288/j.11-2166/r.2025.11.009.
目的
2
观察疏肝健脾颗粒口服联合除湿止痒软膏外用治疗特应性皮炎合并睡眠障碍肝郁脾虚证患者的疗效,并探讨可能作用机制。
方法
2
将66例特应性皮炎合并睡眠障碍肝郁脾虚证患者随机分为治疗组及对照组各33例。两组均给予除湿止痒软膏外用,治疗组再予疏肝健脾颗粒口服,每日1剂;对照组再予盐酸西替利嗪片口服,每日10 mg,睡前服用。两组均治疗4周。治疗结束后统计特应性皮炎临床疗效,并分别于治疗前后记录两组患者特应性皮炎指数(SCORAD)评分、瘙痒视觉模拟量表(VAS)评分、失眠严重程度指数(ISI)评分、匹兹堡睡眠质量指数(PSQI)评分,检测血清褪黑素(MLT)、白细胞介素4(IL-4)、白细胞介素6(IL-6)、白细胞介素13(IL-13)、肿瘤坏死因子α(TNF-α)水平。治疗前后检测患者血常规、肝功能、肾功能,同时观察不良事件发生情况。
结果
2
治疗组特应性皮炎临床疗效总有效率为90.63%(29/32),明显高于对照组的66.67%(20/30,
P
<0.05)。治疗后两组患者SCORAD评分、VAS评分、ISI评分、PSQI评分以及血清IL-4、IL-6、IL-13、TNF-α水平较本组治疗前下降,治疗组血清MLT水平上升(
P
<0.05或
P
<0.01)。治疗后两组间比较,治疗组SCORAD评分、ISI评分、PSQI评分、VAS评分、血清IL-4及IL-13水平均低于对照组,而MLT水平则高于对照组(
P
<0.05或
P
<0.01)。治疗前后两组血常规、肝功能、肾功能均无明显异常,治疗组不良反应发生率为9.38%(3/32),对照组为13.33%(4/30),两组比较差异无统计学意义(
P
>0.05)。
结论
2
在除湿止痒软膏外用基础上联合应用疏肝健脾颗粒口服,可明显减轻特应性皮炎合并睡眠障碍肝郁脾虚证患者皮损和瘙痒程度,改善睡眠质量,其机制可能与调节免疫平衡、减少炎症因子分泌、提升MLT水平有关。
Objective
2
To explore the effectiveness and potential mechanism of
Shugan Jianpi Granules
(疏肝健脾颗粒) combined with
Chushi Zhiyang Ointment
(除湿止痒软膏) in the treatment of atopic dermatitis with sleep disturbance of liver constraint and spleen deficiency syndrome.
Methods
2
Sixty-six patients with atopic dermatitis combined with sleep disturbance of liver constraint and spleen deficiency syndrome were randomly divided into 33 cases each in the treatment group and the control group. Both groups were treated with
Chushi Zhiyang Ointment
for external use. The treatment group additionally received
Shugan Jianpi Granules
orally, one dose per day; and the control group received cetirizine hydrochloride tablets orally, 10mg per day, taken before bedtime. Both groups were under the treatment for 4 weeks. Clinical effectiveness was evaluated after treatment, and the SCORing Atopic Dermatitis (SCORAD) index, pruritus visual analog scale (VAS) score, Insomnia Severity Index (ISI) score, and Pittsburgh Sleep Quality Index (PSQI) score were recorded before and after treatment, and serum levels of melatonin (MLT), interleukin-4 (IL-4), interleukin-6 (IL-6), interleukin-13 (IL-13), and tumor necrosis factor-α (TNF-α) were measured. The patients were also tested for blood routine, liver function and kidney function before and after treatment, and the occurrence of adverse events was also observed.
Results
2
The total effective rate in the treatment group (90.63%, 29/32) was significantly higher than that in the control group (66.67%, 20/30,
P
<0.05). After the interventions, the scores for SCORAD, VAS, ISI, and PSQI, as well as the levels of IL-4, IL-6, IL-13, and TNF-α, were significantly reduced in both groups. In contrast, the MLT levels in treatment group significantly e
levated compared to that before treatment (
P
<0.05). Comparing between the two groups after treatment, the scores of SCORAD, ISI, PSQI, and VAS, as well as the levels of serum IL-4 and IL-13 in the treatment group were significantly lower than those in the control group, while the MLT levels were markedly higher than that in the control group (
P
<0.05 or
P
<0.01). There was no obvious abnormality in blood routine, liver function and kidney function in both groups when compared before and after treatment. The incidence rate of adverse reactions was 9.38% (3/32) in the treatment group and 13.33% (4/30) in the control group, and the difference between groups showed no statistical difference (
P
>0.05).
Conclusion
2
On the basis of topical application of
Chushi Zhiyang Ointment
, the combined application of
Shugan Jianpi Granules
can significantly alleviate the degree of skin lesions and itching, and improve the quality of sleep in atopic dermatitis patients with sleep disturbance of liver constraint and spleen deficiency syndrome, and its mechanism may be related to regulating the immune balance, reducing the secretion of inflammatory factors, and elevating the level of MLT.
CAMERON S , DONNELLY A , BRODERICK C , et al . Mind and skin:exploring the links between inflammation,sleep disturbance and neurocognitive function in patients with atopic dermatitis [J]. Allergy , 2024 , 79 ( 1 ): 26 - 36 .
RØNNSTAD ATM , HALLING-OVERGAARD AS , HAMANN CR , et al . Association of atopic dermatitis with depression,anxiety,and suicidal ideation in children and adults: a systematic review and meta-analysis [J]. J Am Acad Dermatol , 2018 , 79 ( 3 ): 448 - 456 .
SILVERBERG JI , GELFAND JM , MARGOLIS DJ , et al . Patient burden and quality of life in atopic dermatitis in US adults: a population-based cross-sectional study [J]. Ann Allergy Asthma Immunol , 2018 , 121 ( 3 ): 340 - 347 .
XERFAN EMS , TOMIMORI J , ANDERSEN ML , et al . Sleep disturbance and atopic dermatitis: a bidirectional relationship? [J]. Med Hypotheses , 2020 , 140 : 109637 . doi: 10.1016/j.mehy.2020.109637 http://dx.doi.org/10.1016/j.mehy.2020.109637 .
中华医学会皮肤性病学分会免疫学组 , 特应性皮炎协作研究中心 . 中国特应性皮炎诊疗指南(2020版) [J]. 中华皮肤科杂志 , 2020 , 53 ( 2 ): 81 - 88 .
中华医学会精神科分会 . 中国精神障碍分类与诊断标准 [M]. 3版 . 济南 : 山东科学技术出版社 , 2001 : 150 - 160 .
陈红风 . 中医外科学 [M]. 11版 . 北京 : 中国中医药出版社 , 2021 : 171 - 175 .
李元文 . 中医皮肤病学 [M]. 北京 : 科学出版社 , 2023 : 143 - 147 .
MANKOVA D , DUDYSOVA D , NOVAK J , et al . Reliability and validity of the czech version of the Pittsburgh sleep quality index in patients with sleep disorders and healthy controls [J]. Biomed Res Int , 2021 , 2021 : 5576348 . doi: org/10.1155/2021/5576348 http://dx.doi.org/org/10.1155/2021/5576348 .
高珊珊 , 郭林涛 , 鲍身涛 , 等 . 消风散加减治疗特应性皮炎风湿蕴肤证的临床研究 [J]. 北京中医药 , 2019 , 38 ( 11 ): 1139 - 1141 .
杨艳 , 周欣 , 罗育武 , 等 . 卡介菌多糖核酸联合西替利嗪治疗特应性皮炎的疗效观察 [J]. 皮肤性病诊疗学杂志 , 2010 , 17 ( 4 ): 290 - 291 .
王瑞平 . 随机对照临床试验设计中的样本量估算方法 [J]. 上海医药 , 2023 , 44 ( 1 ): 48 - 52 .
曹卉娟 , 邢建民 , 刘建平 , 等 . 视觉模拟评分法在症状类结局评价测量中的应用 [J]. 中医杂志 , 2009 , 50 ( 7 ): 600 - 602 .
MORIN CM , BELLEVILLE G , BÉLANGER L , et al . The insomnia severity index: psychometric indicators to detect insomnia cases and evaluate treatment response [J]. Sleep , 2011 , 34 ( 5 ): 601 - 608 .
WEIDINGER S , BECK LA , BIEBER T , et al . Atopic dermatitis [J]. Nat Rev Dis Primers , 2018 , 4 ( 1 ): 1 - 20 .
CHANG YS , CHIANG BL . Mechanism of sleep disturbance in children with atopic dermatitis and the role of the circadian rhythm and melatonin [J]. Int J Mol Sci , 2016 , 17 ( 4 ): 462 - 475 .
向展翔 , 王军 . 特应性皮炎发病机制的研究进展 [J]. 牡丹江医学院报 , 2022 , 43 ( 4 ): 127 - 129 .
王欣欣 . 基于Th1/Th2平衡研究沙棘果油及其有效成分对特应性皮炎小鼠的干预作用 [D]. 沈阳 : 辽宁中医药大学 , 2020 .
CHANG YS , CHIANG BL . Sleep disorders and atopic dermatitis: a 2-way street? [J]. J Allergy Clin Immunol , 2018 , 142 ( 4 ): 1033 - 1040 .
CHANG YS , CHOU YT , LEE JH , et al . Atopic dermatitis,melatonin, and sleep disturbance [J]. Pediatrics , 2014 , 134 ( 2 ): e397 - e405 .
PAREKH PJ , OLDFIELD IV EC , CHALLAPALLISRI V , et al . Sleep disorders and inflammatory disease activity: chicken or the egg? [J]. Am J Gastroenterol , 2015 , 110 ( 4 ): 484 - 488 .
FAVERO G , FRANCESCHETTI L , BONOMINI F , et al . Melatonin as an anti-inflammatory agent modulating inflammasome activation [J]. Int J Endocrinol , 2017 , 2017 : 1835195 . doi: org/10.1155/2017/1835195 http://dx.doi.org/org/10.1155/2017/1835195 .
THI HUONG NGUYEN L , CHOI MJ , SHIN HM , et al . Seungmagalgeun-tang, a traditional herbal formula, alleviates skin inflammation and depression-like behavior in atopic dermatitis mice under sleep deprivation conditions [J]. Evid Based Complement Alternat Med , 2022 , 2022 : 1307173 . doi: org/10.1155/2022/1307173 http://dx.doi.org/org/10.1155/2022/1307173 .
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号